North America Contract Research Organization (CRO) Market to 2025 - Regional Analysis and Forecasts by Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, Post-Approval Services); End User (Pharmaceutical & Biotechnology Companies and Medical Device Companies) and Country
- THE3207046
- 150 Pages
- April 2019
- Pharmaceuticals
The growth of the contract research organization (CRO) market is primarily attributed to the increasing R&D expenditures and outsourcing activities and rise in the number of clinical trials. However, the dearth of skilled professionals and regional competition in the CRO services market are likely to pose a negative impact on the market growth. On the other hand, growing biosimilars and biologics market and increasing demand for specialized testing services are likely to have a positive impact on the growth of the North America contract research organization (CRO) market in the coming years.
Clinical trials are the crucial and significant step in discovering whether the medical strategy, treatment, or device is safe and effective for human use. The clinical studies help in understanding and determining the best medical approaches for certain therapeutic area. Clinical trials are conducted primarily to collect data regarding the safety and efficacy of new drug and device development. Before the approval of drug molecules and the medical devices by the regulatory authorities, series of clinical studies are conducted. Increasing prevalence of various communicable and non-communicable diseases are increasing the demand for the development of new drugs or medical devices for the treatment. This is in turn expected to increase the demand of the clinical trial activities for various therapeutic areas. As per the US National Library of Medicine presently approximately, 280, 801 clinical studies have been listed with locations of 50 states and 204 countries in till 2018. The number of registered studies by August 2018, is shows the rise in the number of the registration for the clinical trials.
In 2017, the clinical research services segment held a largest market share of 54.5% of the contract research organization (CRO) market, by type. This segment is also expected to dominate the market in 2025 owing to increasing number of new drug molecules and medical devices for the treatment of various therapeutic areas and the requirement for the fulfillment of stringent regulatory requirements before product approvals. Moreover, the laboratory services segment is anticipated to witness the fastest growth rate of 10.5% during the forecast period, 2018 to 2025 owing to increasing number of clinical trials is expected to rise in the coming near future.
North America contract research organization (CRO) market, based on the end user was segmented into pharmaceutical & biotechnology companies and medical devices companies. The pharmaceutical and biotechnology companies segment is anticipated to grow at a CAGR of 8.2% during the forecast period. Moreover, the medical device companies segment is expected to grow at the fastest rate during the coming years.
Some of the major primary and secondary sources for contract research organization (CRO) included in the report are, Association of Clinical Research Organization (ACRO), Contract Research Organization (CRO), Dubai Health Care City (DHCC), Food & Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA) and others.
PART 1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
PART 2. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - KEY TAKEAWAYS
PART 3. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 North America Contract Research Organization (CRO) Market - By Type
3.2.2 North America Contract Research Organization (CRO) Market - By End User
3.2.3 North America Contract Research Organization (CRO) Market - By Country
3.3 PEST ANALYSIS
PART 4. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET- KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Increasing R&D Expenditures and Outsourcing Activities
4.1.2 Rise in The Number of Clinical Trials
4.2 KEY MARKET RESTRAINTS
4.2.1 Dearth Of Skilled Professionals
4.2.2 Regional Competition in The CRO Services Market
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Growing Biosimilars and Biologics Market
4.3.2 Increasing Demand for Specialized Testing Services
4.4 FUTURE TRENDS
4.4.1 Increasing Market Consolidation
4.5 IMPACT ANALYSIS
PART 5. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - NORTH AMERICA ANALYSIS
5.1 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE FORECASTS AND ANALYSIS
5.2 MARKET POSITIONING
5.3 PERFORMANCE OF KEY PLAYERS
5.4 EXPERT OPINIONS
PART 6. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS - BY TYPE
6.1 OVERVIEW
6.2 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE 2017 & 2025 (%)
6.3 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
6.4 EARLY PHASE DEVELOPMENT SERVICES MARKET
6.4.1 Overview
6.4.2 North America Early Phase Development Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.4.3 Drug Discovery Services
6.4.3.1 Overview
6.4.3.2 North America Drug Discovery Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.4.4 Pre-Clinical Services
6.4.4.1 Overview
6.4.4.2 North America Pre-Clinical Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 CLINICAL RESEARCH SERVICES
6.5.1 Overview
6.5.2 North America Clinical Research Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 LABORATORY SERVICES
6.6.1 Overview
6.6.2 North America Laboratory Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 POST-APPROVAL SERVICES
6.7.1 Overview
6.7.2 North America Post-Approval Services Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS - BY END USER
7.1 OVERVIEW
7.2 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY END USER, 2017 & 2025 (%)
7.3 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
7.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
7.4.1 Overview
7.4.2 North America Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 MEDICAL DEVICE COMPANIES
7.5.1 Overview
7.5.2 North America Medical Device Companies Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025
8.1 OVERVIEW
8.2 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.2.1 North America Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.2.1.1 North America Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.2.2 North America Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By End User (US$ Mn)
8.3 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SHARE, BY COUNTRY (2017 & 2025) (%)
8.4 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.4.1 US Contract Research Organization (CRO) Market revenue And Forecasts to 2025 (US$ Mn)
8.4.2 US Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.4.2.1 US Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.4.3 US Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By End User (US$ Mn)
8.5 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.5.1 Canada Contract Research organization (CRO) Market Revenue And Forecasts to 2025 (US$ Mn)
8.5.2 Canada Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.5.2.1 Canada Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.5.3 Canada Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By End User (US$ Mn)
8.6 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.6.1 Mexico Contract Research Organization (CRO) Market Revenue And Forecasts to 2025 (US$ Mn)
8.6.2 Mexico Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.6.2.1 Mexico Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.6.3 Mexico Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By End User (US$ Mn)
PART 9. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET -INDUSTRY LANDSCAPE
9.1 OVERVIEW
9.2 GROWTH STRATEGIES IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, 2015-2018
9.3 INORGANIC GROWTH STRATEGIES
9.3.1 Overview
9.3.2 Merger & Acquisitions
9.3.3 Collaborations
9.3.4 Partnership
9.3.5 Alliance
9.3.6 Agreement & Joint Venture
9.4 ORGANIC GROWTH STRATEGIES
9.4.1 Overview
9.4.2 Launch
9.4.3 Expansion & Relocation
9.4.4 Enhancements
PART 10. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - KEY COMPANY PROFILES
10.1 IQVIA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Information
10.1.4 Service Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 PAREXEL INTERNATIONAL CORPORATION
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Service Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 SYNEOS HEALTH
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Information
10.3.4 Service Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 LABORATORY CORPORATION OF AMERICA HOLDINGS
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Service Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 PRA HEALTH SCIENCES, INC.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Overview
10.5.4 Service Portfolio
10.5.5 Swot Analysis
10.5.6 Key Developments
10.6 CHARLES RIVER
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Service Portfolio
10.6.5 Swot Analysis
10.6.6 Key Developments
10.7 ICON PLC
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Service Portfolio
10.7.5 Swot Analysis
10.7.6 Key Developments
10.8 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Service Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 WUXI APPTEC
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Service Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 MEDPACE
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Service Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
PART 11. APPENDIX
11.1 ABOUT THE INSIGHT PARTNERS
11.2 GLOSSARY OF TERMS
11.3 METHODOLOGY
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
LIST OF TABLES
TABLE 1. R&D INVESTMENTS BY MAJOR PHARMACEUTICAL COMPANIES
TABLE 2. R&D INVESTMENTS BY PHRMA MEMBER COMPANIES,2016
TABLE 3. NUMBER OF RESGISTERED STUDIES FOR CLINICAL TRIALS
TABLE 4. RANK OF GLOBAL CROS, IN 2016
TABLE 5. CONSOLIDATION ACROSS THE CRO INDUSTRY
TABLE 6. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 7. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 8. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 9. NORTH AMERICA EARLY PHASE DEVELOPMENT SERVICES MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 10. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$MN)
TABLE 11. US: R&D INVESTMENTS BY PHARMACEUTICAL COMPANIES, (2015-2016)
TABLE 12. US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 13. US EARLY PHASE DEVELOPMENT SERVICES MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 14. US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$MN)
TABLE 15. CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 16. CANADA EARLY PHASE DEVELOPMENT SERVICES MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 17. CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$MN)
TABLE 18. MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 19. MEXICO EARLY PHASE DEVELOPMENT SERVICES MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 20. MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$MN)
TABLE 21. RECENT MERGER & ACQUISITIONS IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
TABLE 22. RECENT COLLABORATIONS IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
TABLE 23. RECENT PARTNERSHIPS IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
TABLE 24. RECENT ALLIANCES IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
TABLE 25. RECENT AGREEMENT & JOINT VENTURE IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
TABLE 26. RECENT LAUNCHES IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
TABLE 27. RECENT EXPANSIONS & RELOCATION IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
TABLE 28. ENHANCEMENTS IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
TABLE 29. GLOSSARY OF TERMS, CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
LIST OF FIGURES
FIGURE 1. US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, REVENUE (US$ MN), BY COUNTRY 2018 & 2025
FIGURE 2. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY TYPE, MARKET SHARE (%), 2017
FIGURE 3. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY END USER, MARKET SHARE (%), 2017
FIGURE 4. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SEGMENTATION
FIGURE 5. NORTH AMERICA PEST ANALYSIS
FIGURE 6. NUMBER OF APPROVALS FOR NDA & BLA (2005 TO 2016)
FIGURE 7. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 8. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025
FIGURE 9. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BREAKDOWN, BY TYPE 2017 & 2025 (%)
FIGURE 10. NORTH AMERICA EARLY PHASE SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 11. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 12. NORTH AMERICA PRE-CLINICAL TRIAL SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 13. NORTH AMERICA CLINICAL RESEARCH SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 14. NORTH AMERICA LABORATORY SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 15. NORTH AMERICA POST-APPROVAL SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 16. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY END USER, 2017 & 2025 (%)
FIGURE 17. NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 18. NORTH AMERICA MEDICAL DEVICE COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 19. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)
FIGURE 20. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 21. NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SHARE, BY COUNTRY (2017 & 2025) (%)
FIGURE 22. US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 23. CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 24. MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 25. GROWTH STRATEGIES IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, 2015-2018
FIGURE 26. INORGANIC GROWTH STRATEGIES IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, 2015-2018
FIGURE 27. ORGANIC GROWTH STRATEGIES IN THE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, 2015-2018
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
